Introduction Human adult dental pulp stem cells (hDPSC) and stem cells from human
exfoliated deciduous teeth (SHED) hold promise in bone regeneration for their easy …

Mesenchymal stromal cells nowadays emerge as a major player in the field of regenerative
medicine and translational research. They constitute, with their derived products, the most …

In the oral and maxillofacial region, the treatment of severe bone defects, caused by
fractures, cancers, congenital abnormalities, etc., remains a great challenge. In addition …

Ischemic stroke (IS) causes severe disability and high mortality worldwide. Stem cell (SC)
therapy exhibits unique therapeutic potential for IS that differs from current treatments. SC's …

The Dental Pulp of permanent human teeth is home to stem cells with remarkable
multilineage differentiation ability: human Dental Pulp Stem Cells (DPSCs). These cells …

Despite significant advancements in dental tissue restoration and the use of prostheses for
addressing tooth loss, the prevailing clinical approaches remain somewhat inadequate for …

Dental pulp stem cells (DPSCs) have received a lot of attention as a regenerative medicine
tool with strong immunomodulatory capabilities. The excessive inflammatory response …

Mesenchymal stromal/stem cells (MSCs) are multipotent cells with differentiation,
immunoregulatory and regenerative properties. Because of these features, they represent …

The World Health Organization reports that cardiovascular diseases (CVDs) represent 32%
of all global deaths. The ineffectiveness of conventional therapies in CVDs encourages the …

Teeth and their associated tissues contain several populations of mesenchymal stem cells,
one of which is represented by dental pulp stem cells (DPSCs). These cells have mainly …